The BDNF promoter region methylation and depression severity and treatment outcomes were the subjects of a recent editorial in Epigenomics (Reynolds, 2021), in which different studies, as early as 2013, indicated a role of epigenetic regulation associated with early life adverse events that predict different mood disorders later in life. This evidence concerns the gene BDNF and depressive symptom measurement.